347 related articles for article (PubMed ID: 33827675)
61. Effects of age on the glucose metabolic changes in mild cognitive impairment.
Kantarci K; Senjem ML; Lowe VJ; Wiste HJ; Weigand SD; Kemp BJ; Frank AR; Shiung MM; Boeve BF; Knopman DS; Petersen RC; Jack CR
AJNR Am J Neuroradiol; 2010 Aug; 31(7):1247-53. PubMed ID: 20299441
[TBL] [Abstract][Full Text] [Related]
62.
Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
[TBL] [Abstract][Full Text] [Related]
63. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
Cacciamani F; Tandetnik C; Gagliardi G; Bertin H; Habert MO; Hampel H; Boukadida L; Révillon M; Epelbaum S; Dubois B;
J Alzheimers Dis; 2017; 59(2):753-762. PubMed ID: 28671134
[TBL] [Abstract][Full Text] [Related]
64. Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
Cerman J; Andel R; Laczo J; Vyhnalek M; Nedelska Z; Mokrisova I; Sheardova K; Hort J
Curr Alzheimer Res; 2018; 15(3):219-228. PubMed ID: 29165083
[TBL] [Abstract][Full Text] [Related]
65. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
[TBL] [Abstract][Full Text] [Related]
66. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
67. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
[TBL] [Abstract][Full Text] [Related]
68. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
69. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.
Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K
J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473
[TBL] [Abstract][Full Text] [Related]
70. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
71. Functional and structural alterations of dorsal attention network in preclinical and early-stage Alzheimer's disease.
Wu H; Song Y; Yang X; Chen S; Ge H; Yan Z; Qi W; Yuan Q; Liang X; Lin X; Chen J
CNS Neurosci Ther; 2023 Jun; 29(6):1512-1524. PubMed ID: 36942514
[TBL] [Abstract][Full Text] [Related]
72. Cognitive dysfunction in patients with very mild Alzheimer's disease and amnestic mild cognitive impairment showing hemispheric asymmetries of hypometabolism on ¹⁸F-FDG PET.
Murayama N; Ota K; Kasanuki K; Kondo D; Fujishiro H; Fukase Y; Tagaya H; Sato K; Iseki E
Int J Geriatr Psychiatry; 2016 Jan; 31(1):41-8. PubMed ID: 25820930
[TBL] [Abstract][Full Text] [Related]
73. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
[TBL] [Abstract][Full Text] [Related]
74. Early detection of amyloid load using
Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M
Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598
[TBL] [Abstract][Full Text] [Related]
75. Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
McLimans KE; Willette AA;
J Alzheimers Dis; 2017; 56(1):403-413. PubMed ID: 27911319
[TBL] [Abstract][Full Text] [Related]
76. Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects.
Squarzoni P; Faria DP; Yassuda MS; Porto FHG; Coutinho AM; Costa NAD; Nitrini R; Forlenza OV; Duran FLS; Brucki SMD; Buchpiguel CA; Busatto GF
J Alzheimers Dis; 2020; 78(1):229-244. PubMed ID: 32986673
[TBL] [Abstract][Full Text] [Related]
77. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
[TBL] [Abstract][Full Text] [Related]
78. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
[TBL] [Abstract][Full Text] [Related]
79. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
80. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
